Citations

Mayo Clinic

Showing 10 of 108602 citations.

Infantile perianal pyramidal protrusion: A retrospective review of 27 patients
Dhami, Ramneek K. , Isaq, Nasro A., Tollefson, Megha M.

Pediatric Dermatology | March 27, 2023 | Volume: 40 | Issue: 3 | Pages: 468-471

10.1111/pde.15307 | PMID 36967585 Get It

AbstractBackgroundInfantile perianal pyramidal protrusion (IPPP) is a rare benign skin condition that is typically seen in infant girls. This condition is often mistaken for other skin lesions such as acrochordons, condyloma acuminatum, and sequelae of sexual abuse. Many clinicians are unfamiliar with IPPP which can lead to aggressive workup and treatment. The purpose of this study was to elucidate demographic data, clinical features, diagnostic workup, and management of IPPP in a large cohort of patients seen at an academic medical center.MethodsA retrospective review of patients diagnosed with IPPP at Mayo Clinic, Rochester, MN was conducted. Demographic data, examination findings, diagnostic workup, and treatments were noted.ResultsTwenty‐seven patients with IPPP, 24 of which were girls and 3 were boys from the ages of 1 day to 4 years (mean 10.8 months, median 8.6 months) were identified. Symptoms were reported in 63% (17/27) of patients. Four patients received treatment with topical corticosteroid or local anesthetic. No patient underwent skin biopsy.ConclusionIPPP is commonly observed in healthy prepubertal girls. Constipation is a common symptom. Awareness of this entity may prevent overtreatment and unnecessary evaluation.
Threshold-Responsive Colorimetric Sensing System for the Continuous Monitoring of Gases
Mo, Manni , Fu, Bo , Hota, Piyush , Cay-Durgun, Pinar , Cheng, Edward H., Wiktor, Peter , Tsow, Francis , Thomas, Leslie F., Lind, Mary Laura , Forzani, Erica , Thomas, Leslie, Wang, Ran

Sensors | March 27, 2023 | Volume: 23 | Issue: 7 | Pages: 3496

10.3390/s23073496 | PMID 37050555 Get It

Colorimetric sensors are widely used because of their inherent advantages including accuracy, rapid response, ease-of-use, and low costs; however, they usually lack reusability, which precludes the continuous use of a single sensor. We have developed a threshold-responsive colorimetric system that enables repeated analyte measurements by a single colorimetric sensor. The threshold responsive algorithm automatically adjusts the sensor exposure time to the analyte and measurement frequency according to the sensor response. The system registers the colorimetric sensor signal change rate, prevents the colorimetric sensor from reaching saturation, and allows the sensor to fully regenerate before the next measurement is started. The system also addresses issues common to colorimetric sensors, including the response time and range of detection. We demonstrate the benefits and feasibility of this novel system, using colorimetric sensors for ammonia and carbon dioxide gases for continuous monitoring of up to (at least) 60 detection cycles without signs of analytical performance degradation of the sensors.
Overcoming translational barriers in H3K27-altered diffuse midline glioma: Increasing the drug-tumor residence time
Power, Erica A. , Rechberger, Julian S. , Zhang, Liang , Oh, Ju‐Hee , Anderson, Jacob B. , Ge, Jizhi, Hinchcliffe, Edward H. , Elmquist, William F. , Nesvick, Cody L. , Power, Erica A , Rechberger, Julian S , Anderson, Jacob B , Daniels, David J.

Neuro-Oncology Advances | March 27, 2023 | Volume: 5 | Issue: 1 | Pages: No page available

10.1093/noajnl/vdad033 | PMID 37128506 Get It

Abstract Background H3K27-altered diffuse midline glioma (DMG) is the deadliest pediatric brain tumor; despite intensive research efforts, every clinical trial to date has failed. Is this because we are choosing the wrong drugs? Or are drug delivery and other pharmacokinetic variables at play? We hypothesize that the answer is likely a combination, where optimization may result in a much needed novel therapeutic approach. Methods We used in vitro drug screening, patient samples, and shRNA knockdown models to identify an upregulated target in DMG. A single small molecule protein kinase inhibitor with translational potential was selected for systemic and direct, loco-regional delivery to patient-derived xenografts (PDX) and genetically engineered mouse models (GEMM). Pharmacokinetic studies were conducted in non-tumor bearing rats. Results Aurora kinase (AK) inhibitors demonstrated strong antitumor effects in DMG drug screens. Additional in vitro studies corroborated the importance of AK to DMG survival. Systemic delivery of alisertib showed promise in subcutaneous PDX but not intracranial GEMM and PDX models. Repeated loco-regional drug administration into the tumor through convection-enhanced delivery (CED) was equally inefficacious, and pharmacokinetic studies revealed rapid clearance of alisertib from the brain. In an effort to increase the drug to tumor residence time, continuous CED over 7 days improved drug retention in the rodent brainstem and significantly extended survival in both orthotopic PDXs and GEMMs. Conclusions These studies provide evidence for increasing drug-tumor residence time of promising targeted therapies via extended CED as a valuable treatment strategy for DMG.
Prevention of the Vertical Transmission of HIV; A Recap of the Journey so Far
Cárdenas, María C. , Farnan, Sheila, Hamel, Benjamin , Plazas, Maria C. Mejia , Sintim-Aboagye, Elise, Littlefield, Dawn, Punia, Sohan, Enninga, Elizabeth Ann L. , Temesgen, Zelalem , Theiler, Regan N. , Gray, Clive M. , Chakraborty, Rana , Cardenas, Maria Camila, Mejia Plazas, Maria Camila, Littlefield, Dawn R, Behl, Supriya, Enninga, Elizabeth Ann L , Theiler, Regan , Gray, Clive M , Chakraborty, Rana , Behl, Supriya , Johnson, Erica L.

Viruses | March 27, 2023 | Volume: 15 | Issue: 4 | Pages: 849

10.3390/v15040849 | PMID 37112830 Get It

In 1989, one in four (25%) infants born to women living with HIV were infected; by the age of 2 years, there was 25% mortality among them due to HIV. These and other pieces of data prompted the development of interventions to offset vertical transmission, including the landmark Pediatric AIDS Clinical Trial Group Study (PACTG 076) in 1994. This study reported a 67.5% reduction in perinatal HIV transmission with prophylactic antenatal, intrapartum, and postnatal zidovudine. Numerous studies since then have provided compelling evidence to further optimize interventions, such that annual transmission rates of 0% are now reported by many health departments in the US and elimination has been validated in several countries around the world. Despite this success, the elimination of HIV’s vertical transmission on the global scale remains a work in progress, limited by socioeconomic factors such as the prohibitive cost of antiretrovirals. Here, we review some of the key trials underpinning the development of guidelines in the US as well as globally, and discuss the evidence through a historic lens.
Using Machine Learning to Predict Antidepressant Treatment Outcome From Electronic Health Records
Xu, Zhenxing , Vekaria, Veer , Wang, Fei , Cukor, Judith, Adekkanattu, Prakash , Brandt, Pascal , Jiang, Guoqian , Kiefer, Richard C. , Pathak, Jyotishman , Vekaria, Veer , Su, Chang , Luo, Yuan , Rasmussen, Luke V. , Xu, Jie , Xiao, Yunyu , Alexopoulos, George S.

Psychiatric Research and Clinical Practice | March 27, 2023 | Volume: 5 | Issue: 4 | Pages: 118-125

10.1176/appi.prcp.20220015 | PMID 38077277 Get It

Diabetes Management through Telementoring of Primary Care Providers and Community Health Workers: Changes in Patient-Reported Outcomes
Saad, Andrea Dávila, Billings, John, Blecker, Saul , Bouchonville, Matthew F. , Chavez, Cindy, Arora, Sanjeev , Paul, Margaret M. , Berry, Carolyn A.

No container title available | March 27, 2023 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.21203/rs.3.rs-2644730/v1 Get It

Abstract Background Endocrine ECHO (Extension for Community Healthcare Outcomes) is a scalable model of healthcare education that extends enhanced training through ongoing telementoring of community primary care providers (PCPs) by a team of specialists. The purpose of this study was to assess whether patients of providers engaged in the Endocrine ECHO program (Endo ECHO) exhibited improvements in lifestyle, and self-management behaviors. Methods A sample of 533 adult Endo ECHO patients diagnosed with type 1 or complex type 2 diabetes (insulin dependent and/or with an HbA1c of 9% or higher) took a comprehensive survey during Endo ECHO study enrollment (pre-test) and again after at least one year past their first exposure to the intervention (post-test). We assessed pre/post changes in patient-reported outcomes on well-being, lifestyle, and self-management behaviors using McNemar’s tests for paired data. Results A broad array of patients’ self-reported well-being, lifestyle, and self-management behaviors improved over the course of their engagement in the Endo ECHO program. Despite relatively low average health literacy and numeracy, patients’ confidence and self-efficacy to manage their disease also improved significantly from pre-test to post-test. Discussion Endo ECHO may be an effective means of enhancing primary care for individuals with type 1 and complex type 2 diabetes and improving patient capacity to perform the extensive array of lifestyle and self-care behaviors necessary to effectively manage their diabetes outside of the clinical setting. Conclusions The ECHO model of care has been shown to improve provider and satisfaction, quality of care, and in some cases clinical outcomes across various program areas. This study indicates that endocrinology-focused ECHO programs may also lead to behavior changes among patients in between visits to their provider. Further research should examine the impact of the ECHO model on patient behavior.
Efficacy and Safety of Clonidine in the Treatment of Acute Mania in Bipolar Disorder: A Systematic Review
Singal, Prakamya , Núñez, Nicolás A. , Hassett, Leslie C. , Seshadri, Ashok , Singh, Balwinder , Joseph, Boney , Hassett, Leslie C , Singh, Balwinder , Joseph, Boney

Brain Sciences | March 27, 2023 | Volume: 13 | Issue: 4 | Pages: 547

10.3390/brainsci13040547 | PMID 37190511 Get It

Clonidine, an alpha-2 adrenergic agonist, has been proposed as an antimanic agent that acts by reducing noradrenergic transmission. We conducted a systematic review to examine the efficacy and safety of clonidine for acute mania/hypomania. A comprehensive literature search was performed to identify randomized controlled trials (RCT) and non-randomized studies investigating the efficacy and safety of monotherapy/adjuvant treatment with clonidine for acute mania/hypomania in patients with bipolar disorder (BD). Nine studies (n = 222) met our inclusion criteria, including five RCTs (n = 159) and four non-randomized studies (n = 63). Non-randomized studies showed clonidine to help reduce symptoms of mania. However, data from placebo controlled RCTs were inconsistent. One RCT showed adjuvant clonidine as superior to placebo, whereas another RCT reported that clonidine was not better than placebo. In individual RCTs, lithium and valproate offered better antimanic effects compared to clonidine. Studies reported hypotension, depression, and somnolence as common adverse effects. Significant differences in study design and sample size contributed to high heterogeneity. This systematic review suggests low-grade evidence for clonidine as an adjuvant treatment for acute mania with mood stabilizers and inconclusive efficacy as monotherapy, warranting further well-designed RCTs.
Boric acid transport activity of marine teleost aquaporins expressed in Xenopus oocytes
Kumagai, Shiori, Watanabe, Érika Ohta , Hayashi, Naoko, Kimura, Yuuri, Nagashima, Ayumi , Ushio, Kazutaka , Imaizumi, Genki, Munakata, Keijiro, Umezawa, Takahiro, Hirose, Shigehisa , Kasai, Koji, Romero, Michael F. , Kato, Akira , Nagashima, Ayumi , Ushio, Kazutaka , Romero, Michael F , Kato, Akira , Kamiya, Takehiro , Kim, Juhyun , Fujiwara, Toru

Physiological Reports | March 27, 2023 | Volume: 11 | Issue: 6 | Pages: No page available

10.14814/phy2.15655 | PMID 36967473 Get It

AbstractMarine teleosts ingest large amounts of seawater containing various ions, including 0.4 mM boric acid, which can accumulate at toxic levels in the body. However, the molecular mechanisms by which marine teleosts absorb and excrete boric acid are not well understood. Aquaporins (Aqps) are homologous to the nodulin‐like intrinsic protein (NIP) family of plant boric acid channels. To investigate the potential roles of Aqps on boric acid transport across the plasma membrane in marine teleosts, we analyzed the function of Aqps of Japanese pufferfish (Takifugu rubripes) expressed in Xenopus laevis oocytes. Takifugu genome database contains 16 genes encoding the aquaporin family members (aqp0a, aqp0b, aqp1aa, aqp1ab, aqp3a, aqp4a, aqp7, aqp8bb, aqp9a, aqp9b, aqp10aa, aqp10bb, aqp11a, aqp11b, aqp12, and aqp14). When T. rubripes Aqps (TrAqps) were expressed in X. laevis oocytes, a swelling assay showed that boric acid permeability was significantly increased in oocytes expressing TrAqp3a, 7, 8bb, 9a, and 9b. The influx of boric acid into these oocytes was also confirmed by elemental quantification. Electrophysiological analysis using a pH microelectrode showed that these TrAqps increase B(OH)3 permeability. These results indicate that TrAqp3a, 7, 8bb, 9a, and 9b act as boric acid transport systems, likely as channels, in marine teleosts.
Diagnosis, knowledge, perception, and productivity impact of headache education and clinical evaluation program in the workplace at an information technology company of more than 70,000 employees
Sakai, Fumihiko , Igarashi, Hisaka, Yokoyama, Masako, Dhaem, Olivia Begasse de , Kato, Hirohisa, Azuma, Yasuhiro, Koh, Rachel , Phillips, Heather, Singh, Nim, Craven, Audrey, MIYAKE, Hitoshi, Begasse de Dhaem, Olivia , Moran, Heather , Phillips, Heather, Dodick, David W. , Miyake, Hitoshi

Cephalalgia | March 27, 2023 | Volume: 43 | Issue: 4 | Pages: No page available

10.1177/03331024231165682 | PMID 36967710 Get It

Background Migraine is a highly prevalent, disabling, misunderstood, underdiagnosed, and undertreated neurological disease. It is a leading cause of productivity loss in the workplace. Methods This is the first large-scale company-wide headache education and evaluation program in the workplace. Results 73,432 (90.5%) Fujitsu employees participated. The prevalence of migraine was 16.7%, tension-type headache 40.7%, and cluster headache 0.5%. After completing the training, 82.9% of participants without headache said they would change their attitude towards colleagues with headache disorders and 72.5% of total participants said their understanding of headache changed. The proportion of employees who thought that headache had a significant impact on people’s lives increased from 46.8% to 70.6%; 2971 (4.1%) of all participants were interested in a virtual consultation with a headache specialist as part of the program, more than half of whom had not previously consulted for headache. Approximately 14.7 days per year of full productivity per employee with headache were gained resulting in an annual productivity saving per employee of US$4531. Conclusion This unique headache workplace program was associated with a high level of participation, an improvement in the understanding of migraine and attitude towards colleagues with migraine, reduction in disability and increased employee productivity, and decreased costs of lost productivity due to migraine. Workplace programs for migraine should be considered for all industry sectors.
Palbociclib in Combination with Chemotherapy in Pediatric and Young Adult Patients with Relapsed/Refractory Acute Lymphoblastic Leukemia and Lymphoma: A Children’s Oncology Group Study (AINV18P1)
Raetz, Elizabeth A. , Liu, Xiaowei , Norris, Robin E. , Denic, Kristina Z., Reid, Joel, Evensen, Nikki A. , Gore, Lia , Fox, Elizabeth , Weigel, Brenda J. , Carroll, William L. , Norris, Robin E , Evensen, Nikki A , Teachey, David T. , Minard, Charles G. , Loh, Mignon L.

No container title available | March 27, 2023 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.22541/au.167989700.00930360/v1 Get It

Background Cyclin D has been shown to play an essential role in acute lymphoblastic leukemia (ALL) initiation and progression, providing rationale for targeting the CDK4/6-cyclin D complex that regulates cell cycle progression. Procedure The Children’s Oncology Group AINV18P1 phase 1 trial evaluated the CDK4/6 inhibitor, palbociclib, in combination with standard four-drug reinduction chemotherapy in children and young adults with relapsed/refractory B- and T-cell lymphoblastic leukemia (ALL) and lymphoma. Palbociclib (50 mg/m 2 /dose) was administered orally once daily for 21 consecutive days, first as a single agent (days 1-3) and subsequently combined with reinduction chemotherapy. This two-part study was designed to determine the maximum tolerated dose (MTD) or recommended phase 2 dose (RP2D) followed by an expansion pharmacokinetic (PK) cohort. Results Twelve heavily pretreated patients enrolled, all of whom were evaluable for toxicity. One dose-limiting hematologic toxicity (DLT) occurred at the starting dose of 50 mg/m 2 /dose orally for 21 days. No additional DLTs were observed in the dose determination or PK expansion cohorts and overall rates of grade 3/4 non-hematologic toxicities were comparable to those observed with the chemotherapy platform alone. Five complete responses were observed, two among four patients with T-ALL and three among seven patients with B-ALL. Pharmacokinetic studies showed similar profiles with both liquid and capsule formulations of palbociclib. Conclusions Palbociclib in combination with reinduction chemotherapy was well tolerated with a RP2D of 50 mg/m 2 /day for 21 days. Complete responses were observed among heavily pretreated patients.